IP Library Granted Patent US 10,961,506
Granted Patent B2
US 10,961,506 · App. 14/844,717 · Granted Mar 30, 2021

Soluble antibody complexes for T cell or NK cell activation and expansion

Inventor: Andy Isamu Kokaji (Vancouver, CA)
Assignee: STEMCELL Technologies Inc.
C12N5/0646C12N5/0636C12N2501/51C12N2501/515C12N2501/53C12N2501/998
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,961,506
App. No.
14/844,717
Granted
Mar 30, 2021
Kind
B2
Abstract

This disclosure provides compositions and methods for the activation and expansion of human T cells or NK cells using soluble monospecific antibody complexes.

Claims (7)

1. A method of activating human T cells comprising culturing a sample containing human T cells with a composition comprising at least one soluble monospecific complex, wherein

(i) each soluble monospecific complex comprises two antibodies or F(ab′) 2 fragments thereof which are linked and bind to the same antigen on the human T cells, and

(ii) the at least one soluble monospecific complex comprises two anti-CD3 antibodies or F(ab′) 2 fragments thereof that bind a CD3 antigen on the human T cells.

2. The method according to claim 1 wherein the composition further comprises a second soluble monospecific complex that comprises two anti-CD28 antibodies or F(ab′) 2 fragments thereof that bind to a CD28 antigen on the human T cells.

3. The method according to claim 2 wherein the composition further comprises a third monospecific antibody complex that comprises two anti-CD2 antibodies that bind a CD2 antigen on the human T cells.

4. The method according to claim 1 wherein the soluble monospecific complexes are tetrameric antibody complexes.

5. The method according to claim 4 wherein the tetrameric antibody complexes (TAC) are composed of two antibodies from one species bound by two antibody molecules from a second species that bind to the Fc portion of the antibodies of the first animal species.

Assignments (2)
SECURITY INTEREST Recorded Jun 30, 2022
From: STEMCELL TECHNOLOGIES CANADA INC.
To: HSBC BANK CANADA
Reel/Frame 060544/0596 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 2, 2015
From: KOKAJI, ANDY ISAMU
To: STEMCELL TECHNOLOGIES INC.
Reel/Frame 037190/0235 →
Continuity (2)
Provisional Application 62045591 · Sep 4, 2014
Related Publication 20160068811A1 · Mar 10, 2016